Wesana Health, an emerging life sciences company, completed the acquisition of PsyTech, a provider of education, clinical care and clinical tools, for $17m. "The acquisition of PsyTech will greatly accelerate our ability to understand, analyze and improve neurological health and performance by providing a data platform on which to build our technical strategy, clinics in which to apply and accelerate our neuroscience research and relationships with many thousands of the practitioners who will leverage our medicines, diagnostics and technology to heal people," Daniel Carcillo, Wesana CEO.